Innovative Technology Stack Gero leverages advanced AI and cloud-based tools such as Amazon Web Services and Webflow, indicating a strong digital infrastructure that prioritizes scalability and integration—potentially requiring complementary cybersecurity solutions, cloud management services, or AI-driven data analytics tools.
Focus on Longevity Market As a company dedicated to eliminating age-related diseases using preclinical AI research, Gero presents opportunities to provide specialized research tools, lab instrumentation, and biotech partnerships aimed at longevity and age-related healthcare solutions.
Potential Collaborations Gero’s emphasis on sharing valuable research through publications and active engagement in biotech innovation suggests openness to strategic partnerships, particularly in genetic studies, biotech incubators, or clinical data management solutions targeting disease phenotyping and genetic target discovery.
Funding and Growth Opportunities With recent funding of $4.5 million and an expanding team of up to 200 employees, Gero is positioned for accelerated research initiatives and commercial scaling—opportunities exist to offer research services, software solutions, or funding partnerships to support their growth trajectory.
Market Positioning and Trends Operating within the competitive biotech and AI-driven drug discovery space, Gero's focus on shared biology and real-world human data aligns with current trends toward personalized medicine and data-driven healthcare, presenting opportunities to introduce tailored AI solutions, data analytics platforms, or clinical trial support tools.
$10M$25M
$25M$50M
$500M$1B
$1B$10B
$10M$25MGero uses 8 technology products and services including Amazon Web Services, Open Graph, Tilda, and more. Explore Gero's tech stack below.
| Gero Email Formats | Percentage |
| First.Last@gero.ai | 88% |
| FL@gero.ai | 12% |
Biotechnology ResearchCalifornia, United States51-200 Employees
We are a preclinical stage AI drug discovery company with a mission to eliminate age-related diseases We use AI to build clinically relevant disease phenotypes in real-world human data and identify diseases with shared biology. Then WES-enabled genetic study on these phenotypes allows us to discover novel targets applicable to several indications at once. You can find our publications here: https://gero.ai/publications
Company Overview
Media & News
Funding & FinancialsGero has raised a total of $4.5M of funding over 5 rounds. Their latest funding round was raised on Jan 08, 2024 in the amount of $4.5M.
Gero's revenue is estimated to be in the range of $500M$1B
Funding & FinancialsGero has raised a total of $4.5M of funding over 5 rounds. Their latest funding round was raised on Jan 08, 2024 in the amount of $4.5M.
Gero's revenue is estimated to be in the range of $500M$1B
1-888-653-2347 
support@leadiq.com